Evidence map›Paper›PMID 32462972›Full record

ArticleTechnology in cancer research & treatment

Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.

Ziqi Peng, Boyang Xu, Feng Jin

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ziqi PengDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.
Boyang XuDepartment of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.
Feng JinDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.ORCID 0000-0002-3072-8436
First Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to identify novel circular RNAs and the related regulatory axis to provide research targets for the diagnosis and treatment of breast cancer. The circular RNA expression microarray "GSE101123" related to breast cancer was downloaded from the Gene Expression Omnibus database. The differentially expressed circular RNAs between tumor and normal samples were screened using Limma package. The targeted microRNAs of the differentially expressed circular RNAs and the targeted messenger RNAs of the microRNAs were predicted using miRanda and miRWalk, respectively, and a circular RNAs-microRNAs-messenger RNAs network was constructed. Then, functional enrichment analysis, protein-protein interaction network construction, and drug-gene interaction analysis were conducted for the messenger RNAs. A total of 11 differentially expressed circular RNAs were identified between the breast cancer and normal samples, of which 3 were upregulated, while 8 were downregulated. The circular RNA-microRNA-messenger RNA network contained 1 circular RNA (hsa_circ_0000376), 2 microRNAs (miR-1285-3p and miR-1286), and 353 messenger RNAs. The protein-protein interaction network contained 150 nodes and 240 interactions. The hub genes in the protein-protein interaction network were all targeted messenger RNAs of miR-1285-3p that were significantly enriched in the ubiquitin-proteasome system, apoptosis, cell cycle arrest-related pathways, and cancer-related pathways involving SMAD specific E3 ubiquitin protein ligase 1, β-transducin repeat containing E3 ubiquitin protein ligase, tumor protein P53 among others. Twenty-two drugs were predicted to target 4 messenger RNAs, including tumor protein P53. A novel circular RNA, hsa_circ_0000376, was identified in breast cancer that may act as a sponge targeting miR-1285-3p expression which through its target genes,

Indexed as

Gene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorBreast NeoplasmsCell ProliferationFemaleGene Regulatory NetworksHumansMicroRNAsPrognosisProtein Interaction MapsRNA, CircularRNA, MessengerTumor Cells, CulturedBiomarkers, TumorMicroRNAsMIRN1285 microRNA, humanRNA, CircularRNA, Messengercircular RNAcompeting endogenous RNAdifferentially expressed circRNAsmicroRNA protein–protein interaction

Identifiers

PMID32462972
PMCPMC7257864
OpenAlexW3031491161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.